Abstract: A process wherein all of the unsaturates within a cracked naphtha stream are substantially hydrogenated to alkanes and the olefin depleted stream is then subjected to hydrodesulfurization to achieve the desired sulfur levels without the formation of recombinant mercaptans.

Abstract: A process wherein all of the unsaturates within a cracked naphtha stream are substantially hydrogenated to alkanes and the olefin depleted stream is then subjected to hydrodesulfurization to achieve the desired sulfur levels without the formation of recombinant mercaptans.

Abstract: A blood collection device for use with vacuum sample tube is provided having a retractable carrier for a double cannula. A compress spring is mounted between the carrier and the proximal end of the barrel to bias the carrier backward into the barrel. A releasable retaining means is provided to retain the carrier in the proximal end with one end of the double cannula exposed for use. When the retaining means is released the carrier is automatically retracted into the barrel. A cap is provided to cover the original open end and a resealable puncture pad covers the proximal end after the carrier has been retracted.

Abstract: A structural assembly comprises first and second closure parts displaceable between a closed disposition in which they are locked by a locking mechanism and in which they close off the front side of the closure parts from the rear side and an open disposition in which they are spaced apart for access to the rear side of the closure parts and a default indicating device comprising a projection element (34) which is movable to the rear side of the closure parts where it is stowed and which releases when the closure parts move to an open disposition and moves to a projecting position in which it projects from the rear side to the front side of the closure parts to provide a visual warning that the closure parts are not in the closed disposition. The closure parts in one embodiment are fan cowl doors of an aero engine nacelle which are hinged at their upper edges to the upper part of the nacelle and which have bottom edges which move into the closed disposition at the base of the nacelle.

Abstract: This invention is directed to kits for the detection of human islet amyloid polypeptide (IAPP) comprising (a) purified preparations of antibodies which react specifically with insulin or calcitonin gene-related peptides and (b) a preselected amount of human islet amyloid polypeptide which is essentially free of islet amyloid, which polypeptide is one subunit of islet amyloid and which is prepared by depolymerizing human islet amyloid; or a preselected amount of human islet amyloid polypeptide which is essentially free of islet amyloid and has the amino acid sequence: lys-cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Se r-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr.

Abstract: A catalytic distillation structure comprises a plurality of corrugated vertically disposed catalyst containing elements separated by inert spacing elements. The catalyst containing elements each comprise two layers of gas permeable material, such as wire mesh, joined together at regularly spaced intervals to form a single sheet having pockets disposed on the surface. A particulate catalyst is disposed within the pockets. The catalyst within the pockets provides a reaction zone where catalytic reactions may occur and the gas permeable sheets provide mass transfer surfaces to effect a fractional distillation. The spacing elements allow for a variation of the catalyst density and loading.

Abstract: This invention is directed to antibodies which react with human islet amyloid polypeptide and which do not significantly react with insulin or calcitonin gene-related peptides. Preparations of antibodies are provided which bind to islet amyloid polypeptide (IAPP) which is substantially free of islet amyloid, and when isolated from humans, has the following amino acid sequence in positions 1-37:Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val- His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly- Ser-Asn-Thr-Tyr.

Abstract: A catalytic distillation structure which comprises a catalyst component having a porous container having disposed therein, solid particulate catalytic material which swells in use intimately admixed with from 5 to 60 volume % of a deformable material. The catalyst component may be in intimate association with or surrounded by a resilient component, which is comprised of at least 70 volume % open space.

Abstract: Islet Amyloid Polypeptide substantially free of Islet Amyloid which can be isolated from Islet Amyloid of different mammals and when isolated from humans it has the following amino acid sequence in positions 1-37: ##STR1##

Abstract: Subunits of the full length 37 amino acid residue human Islet Amyloid Polypeptide, and feline Islet Amyloid Polypeptide essentially free of unpolymerized amyloid are provided. Islet Amyloid Polypeptide (IAPP) may be isolated and purified from amyloid fibrils using depolymerizing agent and chromatographic techniques. The sequences of the purified Islet Amyloid Polypeptides have been determined Purified Islet Amyloid Polypeptides are suitable for induction of anti-IAPP antibodies.